{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:46:46Z","timestamp":1773190006103,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.ppat.1006628","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T00:00:00Z","timestamp":1506556800000}}],"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Division of Intramural Research program, National Cancer Institute, NIH (US)"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1006628","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T19:27:10Z","timestamp":1505762830000},"page":"e1006628","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma"],"prefix":"10.1371","volume":"13","author":[{"given":"Prabha","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9527-7007","authenticated-orcid":true,"given":"David A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4228-1843","authenticated-orcid":true,"given":"Ravindra P.","family":"Veeranna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6182-8165","authenticated-orcid":true,"given":"Coralie","family":"Viollet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3057-1395","authenticated-orcid":true,"given":"Robert","family":"Yarchoan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"issue":"5192","key":"ref1","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Y Chang","year":"1994","journal-title":"Science"},{"issue":"18","key":"ref2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"E Cesarman","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease","volume":"86","author":"J Soulier","year":"1995","journal-title":"Blood"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/654798","article-title":"An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease","volume":"51","author":"TS Uldrick","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"21","key":"ref5","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1200\/JCO.2003.06.013","article-title":"Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study","volume":"21","author":"C Simonelli","year":"2003","journal-title":"J Clin Oncol"},{"issue":"19","key":"ref6","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","article-title":"Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS","volume":"23","author":"E Boulanger","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Uldrick TS, Bhutani M, Polizzotto MN, Aleman KO, Wyvill KM, Goncalves PH, et al., editors. Inflammatory cytokines, hyperferritinemia and IgE Are prognostic in patients with KSHV-associated lymphomas treated with curative intent therapy. 56th American Society of Hematology Annual Meeting; 2014; San Francisco, CA.","DOI":"10.1182\/blood.V124.21.3001.3001"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00003246-199903000-00016","article-title":"Pleural effusions and hypoxemia","volume":"27","author":"EL Dobyns","year":"1999","journal-title":"Crit Care Med"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1128\/JVI.77.12.6761-6768.2003","article-title":"Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia","volume":"77","author":"M Haque","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1182\/blood.V97.10.3244","article-title":"Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus","volume":"97","author":"DA Davis","year":"2001","journal-title":"Blood"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"H Tian","year":"1997","journal-title":"Genes Dev"},{"issue":"6733","key":"ref12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"PH Maxwell","year":"1999","journal-title":"Nature"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"GL Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"ref14","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"CJ Hu","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","article-title":"The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages","volume":"157","author":"KL Talks","year":"2000","journal-title":"Am J Pathol"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1158\/0008-5472.CAN-04-4130","article-title":"Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells","volume":"65","author":"V Wang","year":"2005","journal-title":"Cancer Res"},{"issue":"22","key":"ref17","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"H Zhong","year":"1999","journal-title":"Cancer Res"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1568009611313030003","article-title":"Oxygen-independent regulation of HIF-1: novel involvement of PI3K\/AKT\/mTOR pathway in cancer","volume":"13","author":"F Agani","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/gad.14.4.391","article-title":"Loss of PTEN facilitates HIF-1-mediated gene expression","volume":"14","author":"W Zundel","year":"2000","journal-title":"Genes Dev"},{"issue":"9","key":"ref20","first-page":"2330","article-title":"Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1","volume":"63","author":"R Fukuda","year":"2003","journal-title":"Cancer Res"},{"issue":"41","key":"ref21","doi-asserted-by":"crossref","first-page":"38205","DOI":"10.1074\/jbc.M203781200","article-title":"Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells","volume":"277","author":"R Fukuda","year":"2002","journal-title":"J Biol Chem"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression","volume":"21","author":"E Laughner","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"6","key":"ref23","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"H Zhong","year":"2000","journal-title":"Cancer Res"},{"issue":"16","key":"ref24","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1128\/JVI.00689-06","article-title":"Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions","volume":"80","author":"Q Cai","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/JVI.05167-11","article-title":"Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors","volume":"86","author":"RP Veeranna","year":"2012","journal-title":"J Virol"},{"issue":"14","key":"ref26","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1128\/JVI.00553-06","article-title":"Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster","volume":"80","author":"M Haque","year":"2006","journal-title":"J Virol"},{"issue":"21","key":"ref27","doi-asserted-by":"crossref","first-page":"10802","DOI":"10.1128\/JVI.00673-06","article-title":"Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors","volume":"80","author":"PA Carroll","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"e1006143","DOI":"10.1371\/journal.ppat.1006143","article-title":"RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature","volume":"13","author":"C Viollet","year":"2017","journal-title":"PLoS Pathog"},{"issue":"23","key":"ref29","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1073\/pnas.1004882107","article-title":"Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells","volume":"107","author":"T Delgado","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"ref30","doi-asserted-by":"crossref","first-page":"10413","DOI":"10.1128\/JVI.00611-07","article-title":"A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia","volume":"81","author":"Q Cai","year":"2007","journal-title":"J Virol"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1371\/journal.ppat.0020116","article-title":"EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors","volume":"2","author":"QL Cai","year":"2006","journal-title":"PLoS Pathog"},{"issue":"17","key":"ref32","first-page":"4873","article-title":"The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha","volume":"60","author":"A Sodhi","year":"2000","journal-title":"Cancer Res"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/0008-5472.CAN-07-2766","article-title":"Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression","volume":"68","author":"YC Shin","year":"2008","journal-title":"Cancer Res"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"e1004400","DOI":"10.1371\/journal.ppat.1004400","article-title":"Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells","volume":"10","author":"O Yogev","year":"2014","journal-title":"PLoS Pathog"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"e1003584","DOI":"10.1371\/journal.ppat.1003584","article-title":"Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis","volume":"9","author":"AM Gallaher","year":"2013","journal-title":"PLoS Pathog"},{"issue":"14","key":"ref36","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"LE Huang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1073\/pnas.080072497","article-title":"Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations","volume":"97","author":"CH Sutter","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"ref38","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1073\/pnas.1205995109","article-title":"Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma","volume":"109","author":"AP Bhatt","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10456-015-9475-4","article-title":"KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma","volume":"18","author":"T Ma","year":"2015","journal-title":"Angiogenesis"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/MCB.01395-06","article-title":"A microRNA signature of hypoxia","volume":"27","author":"R Kulshreshtha","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/1078-0432.CCR-07-1755","article-title":"hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer","volume":"14","author":"C Camps","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molcel.2009.09.006","article-title":"Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation","volume":"35","author":"X Huang","year":"2009","journal-title":"Mol Cell"},{"issue":"17","key":"ref43","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4161\/cc.8.17.9387","article-title":"MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT","volume":"8","author":"Z Zhang","year":"2009","journal-title":"Cell Cycle"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/pcmr.12255","article-title":"Distinct microRNA expression signatures are associated with melanoma subtypes and are regulated by HIF1A","volume":"27","author":"HW Hwang","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4161\/cbt.7.2.5297","article-title":"miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer","volume":"7","author":"A Giannakakis","year":"2008","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2009.08.015","article-title":"MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1\/2","volume":"10","author":"SY Chan","year":"2009","journal-title":"Cell Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e1090","DOI":"10.1038\/cddis.2014.60","article-title":"MiRNA-210 modulates a nickel-induced cellular energy metabolism shift by repressing the iron-sulfur cluster assembly proteins ISCU1\/2 in Neuro-2a cells","volume":"5","author":"M He","year":"2014","journal-title":"Cell Death Dis"},{"issue":"5930","key":"ref48","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"MG Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"1","key":"ref49","first-page":"27","article-title":"Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro","volume":"13","author":"G Medes","year":"1953","journal-title":"Cancer Res"},{"key":"ref50","first-page":"401","article-title":"AKTivation of PI3K\/AKT\/mTOR signaling pathway by KSHV","volume":"3","author":"AP Bhatt","year":"2012","journal-title":"Front Immunol"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cmet.2013.11.022","article-title":"Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth","volume":"19","author":"RC Sun","year":"2014","journal-title":"Cell Metab"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-07-0463","article-title":"Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha","volume":"7","author":"MY Koh","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1535-7163.233.3.3","article-title":"Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha","volume":"3","author":"S Welsh","year":"2004","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/JTO.0b013e3181dc211f","article-title":"Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice","volume":"5","author":"JJ Jacoby","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/JVI.78.4.1918-1927.2004","article-title":"The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway","volume":"78","author":"CC Tomlinson","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/JVI.77.1.57-67.2003","article-title":"The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells","volume":"77","author":"M Cannon","year":"2003","journal-title":"J Virol"},{"issue":"17","key":"ref57","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1128\/JVI.00766-08","article-title":"Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells","volume":"82","author":"VA Morris","year":"2008","journal-title":"J Virol"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1128\/JVI.02119-07","article-title":"Activation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replication","volume":"82","author":"E Kuang","year":"2008","journal-title":"J Virol"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"e1005648","DOI":"10.1371\/journal.ppat.1005648","article-title":"An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing Glycolysis","volume":"12","author":"Y Zhu","year":"2016","journal-title":"PLoS Pathog"},{"issue":"15","key":"ref60","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1073\/pnas.0700690104","article-title":"Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production","volume":"104","author":"JM Funes","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"ref61","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.24.13.5923-5936.2004","article-title":"Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays","volume":"24","author":"JW Kim","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"8","key":"ref62","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood.V94.8.2871","article-title":"Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells","volume":"94","author":"KD Jones","year":"1999","journal-title":"Blood"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coviro.2015.08.016","article-title":"Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis","volume":"14","author":"TF Schulz","year":"2015","journal-title":"Curr Opin Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-12-800098-4.00002-7","article-title":"KSHV: pathways to tumorigenesis and persistent infection","volume":"88","author":"L Giffin","year":"2014","journal-title":"Adv Virus Res"},{"issue":"8","key":"ref65","doi-asserted-by":"crossref","first-page":"e0136142","DOI":"10.1371\/journal.pone.0136142","article-title":"Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells","volume":"10","author":"M Mushtaq","year":"2015","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0076-6879(07)35020-9","article-title":"Hypoxia-inducible factor 1 inhibitors","volume":"435","author":"G Melillo","year":"2007","journal-title":"Methods Enzymol"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nchembio.1185","article-title":"Allosteric inhibition of hypoxia inducible factor-2 with small molecules","volume":"9","author":"TH Scheuermann","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"7","key":"ref68","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.18632\/oncotarget.6995","article-title":"Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling","volume":"7","author":"CW Hsu","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.virol.2004.03.049","article-title":"Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression","volume":"325","author":"J Vieira","year":"2004","journal-title":"Virology"},{"issue":"14","key":"ref70","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/0008-5472.CAN-07-0939","article-title":"Hypoxia enhances the phosphorylation and cytotoxicity of ganciclovir and zidovudine in Kaposi's sarcoma-associated herpesvirus infected cells","volume":"67","author":"DA Davis","year":"2007","journal-title":"Cancer Res"},{"issue":"15","key":"ref71","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1128\/JVI.00742-14","article-title":"Identification of properties of the Kaposi's sarcoma-associated herpesvirus latent origin of replication that are essential for the efficient establishment and maintenance of intact plasmids","volume":"88","author":"P Shrestha","year":"2014","journal-title":"J Virol"},{"issue":"17","key":"ref72","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1158\/0008-5472.CAN-08-0627","article-title":"EBV is necessary for proliferation of dually infected primary effusion lymphoma cells","volume":"68","author":"AA Mack","year":"2008","journal-title":"Cancer Res"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1006628","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T00:00:00Z","timestamp":1506556800000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1006628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T23:56:13Z","timestamp":1659484573000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1006628"}},"subtitle":[],"editor":[{"given":"Erle S.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":72,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1006628","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1006628","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]}}}